• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

vaccines

Treating Parkinson’s Disease: Betting on Alpha-Synuclein
Posted inClinical Trials, In the Pipeline, Neuroscience

Treating Parkinson’s Disease: Betting on Alpha-Synuclein

January 14, 2022September 8, 2022

The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.

Eliminating Health Disparities Is Key to Ending Pandemic
Posted inCOVID-19, Infections, Research

Eliminating Health Disparities Is Key to Ending Pandemic

December 29, 2021September 8, 2022

Misinformation, populism, and self-interest keep the COVID-19 that has enslaved the planet.

coronavirus
Posted inCOVID-19, Infections, Research

Three Billion Omicron Cases

December 25, 2021September 8, 2022

Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.

coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

December 17, 2021September 8, 2022

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.

Universal Coronavirus Vaccine
Posted inCOVID-19, Infections, Research

Universal Coronavirus Vaccine

December 17, 2021September 8, 2022

The biotechnology industry must come up with a comprehensive defense against all coronaviruses.

Do People Who Have Already Had COVID-19 Need to Be Vaccinated?
Posted inCOVID-19, Infections, Research

Do People Who Have Already Had COVID-19 Need to Be Vaccinated?

December 14, 2021September 8, 2022

How long does protective immunity last after a COVID-19 infection?

Sanofi to Make Vaccine Against Acne
Posted inInfections, Pharma & Biotech

Sanofi to Make Vaccine Against Acne

December 2, 2021September 8, 2022

Acne vulgaris treatment will reach a new level of quality.

Posts navigation

Newer posts 1 2 3 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News